⌘K

Login Start Free

HOOKIPA Pharma Inc.·4

Jan 16, 4:06 PM ET

Orlinger Klaus 4

4 · HOOKIPA Pharma Inc. · Filed Jan 16, 2020

Insider Transaction Report

Form 4

Period: 2020-01-14

HOOKIPA Pharma Inc.HOOK

Sr. VP, Research

Transactions

Exercise/Conversion
Common Stock
2020-01-14$0.10/sh+7,358$736→ 7,358 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-01-14−7,358→ 0 total
Exercise: $0.10Exp: 2026-12-31→ Common Stock (7,358 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-01-14−1,142→ 1,140 total
Exercise: $0.10Exp: 2026-12-31→ Common Stock (1,142 underlying)
Exercise/Conversion
Common Stock
2020-01-14$0.10/sh+1,142$114→ 8,500 total
Sale
Common Stock
2020-01-14$11.30/sh−8,500$96,053→ 0 total

Footnotes (1)

[F1]This option is fully vested and exercisable.

Documents

1 file

4
a4.xmlPrimary
4